First Time Loading...
J

JCR Pharmaceuticals Co Ltd
TSE:4552

Watchlist Manager
JCR Pharmaceuticals Co Ltd
TSE:4552
Watchlist
Price: 648 JPY -18.8% Market Closed
Updated: May 14, 2024

JCR Pharmaceuticals Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

JCR Pharmaceuticals Co Ltd
Interest Income Expense Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
J
JCR Pharmaceuticals Co Ltd
TSE:4552
Interest Income Expense
-¥407m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Interest Income Expense
-¥164.5B
CAGR 3-Years
3%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
Interest Income Expense
¥11.2B
CAGR 3-Years
12%
CAGR 5-Years
59%
CAGR 10-Years
N/A
Otsuka Holdings Co Ltd
TSE:4578
Interest Income Expense
¥30.7B
CAGR 3-Years
25%
CAGR 5-Years
8%
CAGR 10-Years
9%
Chugai Pharmaceutical Co Ltd
TSE:4519
Interest Income Expense
¥4.2B
CAGR 3-Years
N/A
CAGR 5-Years
57%
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Interest Income Expense
¥1.1B
CAGR 3-Years
-40%
CAGR 5-Years
-5%
CAGR 10-Years
-19%

See Also

What is JCR Pharmaceuticals Co Ltd's Interest Income Expense?
Interest Income Expense
-407m JPY

Based on the financial report for Dec 31, 2023, JCR Pharmaceuticals Co Ltd's Interest Income Expense amounts to -407m JPY.